中文 | English
Return
Total: 250 , 1/25
Show Home Prev Next End page: GO
Author:(Guang-Ling CHEN)

3.The study of expression of matrix metaUoproteinases-2 in patients with colorectal cancer

Ya MA ; Guang-Ling CAI ; Guang-Yin YU ; Wei-Hua YIN ; Li CHEN ;

Chinese Journal of Primary Medicine and Pharmacy 2005;0(11):-

4.Anti-glioblastoma study of YHP-836, a novel PARP1/2 inhibitor, in combination with temozolomide

Jia-ling DENG ; Ting-ting DU ; Jie ZHOU ; Bai-ling XU ; Xiao-guang CHEN ; Ming JI

Acta Pharmaceutica Sinica 2024;59(6):1656-1663

5.Effects of Early Intervention on Growth Associated Protein-43 and Neuron Cells Apoptosis in Brain of Neonatal Rats

yan-hui, CHEN ; ling, LIU ; min-rong, CHEN ; da-guang, CHEN

Journal of Applied Clinical Pediatrics 2006;0(14):-

6.Synthesis and activity evaluation of PARP-1 inhibitors with azaindole skeleton.

Jie ZHOU ; Zhi-Xiang ZHU ; Xiao-Guang CHEN ; Bai-Ling XU

Acta Pharmaceutica Sinica 2013;48(12):1792-1799

7.Application of shear wave elastography in the evaluation of neck-shoulder myofascial pain syndrome.

Ling GUO ; Chen ZHANG ; Ding-ding ZHANG ; Jing-hua GAO ; Guang-hui LIU ; Shang-quan WANG

China Journal of Orthopaedics and Traumatology 2016;29(2):142-145

8.Design, synthesis and biological evaluation of novel para-substituted 1-benzyl-quinazoline-2, 4 (1H, 3H)-diones as human PARP-1 inhibitors.

Hai-Ping YAO ; Zhi-Xiang ZHU ; Ming JI ; Xiao-Guang CHEN ; Bai-Ling XU

Acta Pharmaceutica Sinica 2014;49(4):497-503

9.Design, synthesis and biological evaluation of novel 3-(2-oxo-2-substituted acetamido)benzamides as PARP-1 inhibitors.

Yu-wen YIN ; Ming JI ; Ran CAO ; Xiao-guang CHEN ; Bai-ling XU

Acta Pharmaceutica Sinica 2015;50(6):738-745

10.Innovation Elements Being in Harmony for Fundamental Medical Physics Experiment

Shi-Guo CHEN ; Xin-Hua LIAO ; Ling DENG ; Xu NING ; Xian-Guang MA ;

Chinese Journal of Medical Education Research 2006;0(10):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 250 , 1/25 Show Home Prev Next End page: GO